Jarislowsky, Fraser LTD Johnson & Johnson Transaction History

Jarislowsky, Fraser LTD

$17.4 Billion
Q1 2024

A detailed history of Jarislowsky, Fraser LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 654,913 shares of JNJ stock, worth $95.6 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

654,913

Previous 682,023 3.97%

Holding current value

$95.6 Million

Previous $107 Million 3.09%

% of portfolio

0.59%

Previous 0.63%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $4.21 Million - $4.41 Million	-27,110 Reduced 3.97%	654,913 $104 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $1 Million - $1.1 Million	-6,896 Reduced 1.0%	682,023 $107 Million
Q3 2023 Nov 06, 2023	SELL	$155.75 - $174.48 $1.63 Million - $1.82 Million	-10,448 Reduced 1.49%	688,919 $107 Million
Q2 2023 Jul 19, 2023	SELL	$154.35 - $166.11 $1.12 Million - $1.2 Million	-7,240 Reduced 1.02%	699,367 $116 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $2.7 Million - $3.22 Million	-17,870 Reduced 2.47%	706,607 $110 Million

Q4 2022 Feb 10, 2023	SELL	$160.2 - $179.79 $2.51 Million - $2.82 Million	-15,668 Reduced 2.12%	724,477 $128 Million
Q3 2022 Nov 07, 2022	SELL	$161.33 - $179.52 $2.2 Million - $2.45 Million	-13,632 Reduced 1.81%	740,145 $121 Million
Q2 2022 Jul 27, 2022	SELL	$168.19 - $186.01 $4.15 Million - $4.59 Million	-24,670 Reduced 3.17%	753,777 $134 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $4.61 Million - $5.24 Million	-29,168 Reduced 3.61%	778,447 $138 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $5.81 Million - $6.45 Million	-37,285 Reduced 4.41%	807,615 $138 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $5.5 Million - $6.11 Million	-34,038 Reduced 3.87%	844,900 $136 Million
Q2 2021 Aug 09, 2021	SELL	$159.48 - $171.07 $5.6 Million - $6 Million	-35,101 Reduced 3.84%	878,938 $145 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $5.12 Million - $5.7 Million	-33,435 Reduced 3.53%	914,039 $150 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $4.41 Million - $5.06 Million	-32,175 Reduced 3.28%	947,474 $149 Million
Q3 2020 Nov 03, 2020	SELL	$140.38 - $153.83 $54.3 Million - $59.5 Million	-386,549 Reduced 28.29%	979,649 $146 Million
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $7.88 Million - $9.51 Million	61,171 Added 4.69%	1,366,198 $192 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $156,818 - $217,279	1,411 Added 0.11%	1,305,027 $171 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $1.23 Million - $1.42 Million	-9,681 Reduced 0.74%	1,303,616 $190 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $1.38 Million - $1.54 Million	-10,861 Reduced 0.82%	1,313,297 $170 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $3.3 Million - $3.63 Million	-25,174 Reduced 1.87%	1,324,158 $184 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $12.2 Million - $13.6 Million	-97,380 Reduced 6.73%	1,349,332 $189 Million
Q4 2018 Feb 01, 2019	SELL	$122.84 - $147.84 $2.21 Million - $2.66 Million	-17,980 Reduced 1.23%	1,446,712 $187 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $7.26 Million - $8.54 Million	-59,748 Reduced 3.92%	1,464,692 $205 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $389,244 - $429,537	-3,260 Reduced 0.21%	1,524,440 $185 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $4.52 Million - $5.35 Million	-36,117 Reduced 2.31%	1,527,700 $0
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $5.22 Million - $5.71 Million	-39,783 Reduced 2.48%	1,563,817 $0
Q3 2017 Nov 06, 2017	BUY	$129.47 - $135.38 $208 Million - $217 Million	1,603,600	1,603,600 $208 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Account

Jarislowsky, Fraser LTD Johnson & Johnson Transaction History